Take Advantage Of The ‘Summer Dip’ With The FTSE 100, AstraZeneca plc & Vodafone Group plc

Now could be a great time to buy AstraZeneca plc (LON: AZN), Vodafone Group plc (LON: VOD) and the FTSE 100 (INDEXFTSE:UKX).

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

FTSE100

‘Sell in May and don’t come back until St. Ledger’s day’ is a well-known saying in investing circles. Indeed, data from recent decades seems to back it up: the stock market rarely embarks on a sustained summer rally and usually falls between May and September. This has been the case in 2014, with the FTSE 100 falling by 1% over the last three months.

This means that the index is flat for the year so far, although it still appears to offer good value for money when compared to its American cousin, the S&P 500. While it trades on a price to earnings (P/E) ratio of 18.5, our FTSE 100 has a P/E of just 13.4. So, while many commentators have been getting excited about our ‘summer dip’ in terms of it being the beginning of a prolonged market correction, it could turn out to be little more than a mild, mundane and entirely predictable summer pullback.

Great Value

As a result of falls in the last few months, many top-notch FTSE 100 stocks are now even better value than they were in May. Two fine examples are AstraZeneca (LSE: AZN) and Vodafone (LSE: VOD). The former has fallen by 1.5% during the last three months, while the latter is down 7% over the same time period. This means that both companies now offer above-average yields of 4% and 5.7% respectively, which highlights their attractive valuations at current price levels.

Looking Ahead

However, there is a lot more to AstraZeneca and Vodafone that attractive prices. For example, AstraZeneca continues to make huge improvements to its drug pipeline and is gradually overcoming a sizeable patent cliff that has caused the company’s top and bottom lines to fall in recent years. Similarly, Vodafone is pursuing a sound strategy of buying undervalued assets in Europe. Although it may take many years for this strategy to come good, it looks set to put Vodafone on a long term path to strong growth and stability, which is great news for shareholders.

Certainly, the ‘summer dip’ may not yet be over. The FTSE 100, including AstraZeneca and Vodafone, may fall further. However, they seem to offer top notch value for money at present and appear to have bright futures. Indeed, with the UK economy continuing to pick up pace, and with interest rates looking less likely to move higher as a result of lower than expected inflation, a purple patch could be just around the corner. As a result, it could be worth coming back a little before St. Ledger’s day!

Peter Stephens owns shares of AstraZeneca. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Group of young friends toasting each other with beers in a pub
Investing Articles

FTSE 100 shares: has a once-a-decade chance to build wealth ended?

The FTSE 100 index has had a strong 2025. But that doesn't mean there might not still be some bargain…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

I asked ChatGPT for its top passive income ideas for 2026 and it said…

Stephen Wright is looking for passive income ideas for 2026. But can asking artificial intelligence for insights offer anything valuable?

Read more »

Woman riding her old fashioned bicycle along the Beach Esplanade at Aberdeen, Scotland.
Investing Articles

Here’s how a 10-share SIPP could combine both growth and income opportunities!

Juggling the prospects of growth and dividend income within one SIPP can take some effort. Our writer shares his thoughts…

Read more »

Tabletop model of a bear sat on desk in front of monitors showing stock charts
Investing Articles

The stock market might crash in 2026. Here’s why I’m not worried

When Michael Burry forecasts a crash, the stock market takes notice. But do long-term investors actually need to worry about…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

Is this FTSE 250 retailer set for a dramatic recovery in 2026?

FTSE 250 retailer WH Smith is moving on from the accounting issues that have weighed on it in 2025. But…

Read more »

Young Black woman using a debit card at an ATM to withdraw money
Investing Articles

I’m racing to buy dirt cheap income stocks before it’s too late

Income stocks are set to have a terrific year in 2026 with multiple tailwinds supporting dividend growth. Here's what Zaven…

Read more »

ISA Individual Savings Account
Investing Articles

Aiming for a £1k passive income? Here’s how much you’d need in an ISA

Mark Hartley does the maths to calculate how much an investor would need in an ISA when aiming for a…

Read more »

Two business people sitting at cafe working on new project using laptop. Young businesswoman taking notes and businessman working on laptop computer.
Investing Articles

Is investing £5,000 enough to earn a £1,000 second income?

Want to start earning a second income in the stock market? Zaven Boyrazian breaks down how investors can aim to…

Read more »